Literature DB >> 9494076

Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

S Gibson1, K Truitt, Y Lu, R Lapushin, H Khan, J B Imboden, G B Mills.   

Abstract

Optimal T cell activation requires crosslinking of the T cell receptor (TCR) concurrently with an accessory receptor, most efficiently CD28. Crosslinking of CD28 leads to increased interleukin 2 (IL2) production, inhibition of anergy and prevention of programmed cell death. Crosslinking of CD28 leads to rapid increases in tyrosine phosphorylation of specific intracellular substrates including CD28 itself. Since CD28 does not encode an intrinsic tyrosine kinase domain, CD28 must activate an intracellular tyrosine kinase(s). Indeed, crosslinking of CD28 increases the activity of the intracellular tyrosine kinases EMT/ITK and LCK. The phosphatidylinositol 3-kinase (PI3K) and GRB2 binding site in CD28 is dispensable for optimal IL2 production in Jurkat T cells. We demonstrate herein that murine Y170 (equivalent to human Y173) in CD28 is also dispensable for activation of the SRC family tyrosine kinase LCK and the TEC family tyrosine kinase EMT/ITK. In contrast, the distal three tyrosines in CD28 are required for optimal IL2 production as well as for optimal activation of the LCK and EMT/ITK tyrosine kinases. The distal three tyrosines of CD28, however, are not required for recruitment of PI3K to CD28. Furthermore, PI3K is recruited to CD28 in JCaM1 cells which lack LCK and in which EMT/ITK is not activated by ligation of CD28. Thus optimal activation of LCK or EMT/ITK is not obligatory for recruitment of PI3K to CD28 and thus is also not required for tyrosine phosphorylation of the YMNM motif in CD28. Taken together the data indicate that the distal three tyrosines in CD28 are integral to the activation of LCK and EMT/ITK and for subsequent IL2 production.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494076      PMCID: PMC1219252          DOI: 10.1042/bj3301123

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity.

Authors:  S D Heyeck; H M Wilcox; S C Bunnell; L J Berg
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

Review 2.  Signal transduction by lymphocyte antigen receptors.

Authors:  A Weiss; D R Littman
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 3.  Signals and signs for lymphocyte responses.

Authors:  C A Janeway; K Bottomly
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

4.  Differential T cell costimulatory requirements in CD28-deficient mice.

Authors:  A Shahinian; K Pfeffer; K P Lee; T M Kündig; K Kishihara; A Wakeham; K Kawai; P S Ohashi; C B Thompson; T W Mak
Journal:  Science       Date:  1993-07-30       Impact factor: 47.728

5.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

6.  Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q.

Authors:  S Gibson; B Leung; J A Squire; M Hill; N Arima; P Goss; D Hogg; G B Mills
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

7.  Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells.

Authors:  N Yamada; Y Kawakami; H Kimura; H Fukamachi; G Baier; A Altman; T Kato; Y Inagaki; T Kawakami
Journal:  Biochem Biophys Res Commun       Date:  1993-04-15       Impact factor: 3.575

8.  Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line.

Authors:  A August; B Dupont
Journal:  Biochem Biophys Res Commun       Date:  1994-03-30       Impact factor: 3.575

9.  T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif.

Authors:  K V Prasad; Y C Cai; M Raab; B Duckworth; L Cantley; S E Shoelson; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells.

Authors:  K E Truitt; C M Hicks; J B Imboden
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  9 in total

Review 1.  ITK inhibitors in inflammation and immune-mediated disorders.

Authors:  Nisebita Sahu; Avery August
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

2.  PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors.

Authors:  Noah Isakov; Amnon Altman
Journal:  Front Immunol       Date:  2012-08-22       Impact factor: 7.561

Review 3.  Signal-transduction defects in T cells.

Authors:  E Grunebaum; C M Roifman
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

4.  Itk: the rheostat of the T cell response.

Authors:  Juris A Grasis; Constantine D Tsoukas
Journal:  J Signal Transduct       Date:  2011-04-07

5.  RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation.

Authors:  K Rajagopal; C L Sommers; D C Decker; E O Mitchell; U Korthauer; A I Sperling; C A Kozak; P E Love; J A Bluestone
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

6.  Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation.

Authors:  A D Holdorf; J M Green; S D Levin; M F Denny; D B Straus; V Link; P S Changelian; P M Allen; A S Shaw
Journal:  J Exp Med       Date:  1999-08-02       Impact factor: 14.307

7.  Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk.

Authors:  W Ellmeier; S Jung; M J Sunshine; F Hatam; Y Xu; D Baltimore; H Mano; D R Littman
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

8.  Simulation of the dynamics of primary immunodeficiencies in CD4+ T-cells.

Authors:  Gabriel N Teku; Mauno Vihinen
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

9.  Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation.

Authors:  Chang-Hung Chen; Carole Seguin-Devaux; Nancy A Burke; Timothy B Oriss; Simon C Watkins; Neil Clipstone; Anuradha Ray
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.